New study finds third dose of COVID-19 vaccine is crucial for immunocompromised patients.

"A third dose of COVID-19 vaccination triggers vital long-term protection for immunocompromised patients, a new study led by Monash University has found."

“Our research emphasises that vaccine boosters remain critical for people with immune disorders, to increase their lower protection levels.”

Source: https://www.nationaltribune.com.au/new-study-finds-third-dose-of-covid-19-vaccine-is-crucial-for-immunocompromised-patients/

Study: https://www.medrxiv.org/content/10.1101/2025.11.09.25339598v1